Form 4 for CYTK CYTOKINETICS INC
Accepted 2025-11-12 00:00:00 ET · period of report 2025-11-11 · accession 0001061983-25-000031 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-11-12 | 2025-11-11 | CYTK | Kaye Edward M. MD | Dir | S - Sale+OE | $65.08 | -5,175 | 9,977 | -34% | -$336.8K |
| D | 2025-11-12 | 2025-11-11 | CYTK | Kaye Edward M. MD | Dir | M - OptEx | $9.66 | +5,175 | 15.2K | +52% | +$50.0K |
| D | 2025-11-12 | 2025-11-11 | CYTK | Kaye Edward M. MD | Dir | M - OptEx | $0.00 | -5,175 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-11 | S | D | 5,175 | $65.08 | 9,977 | D | — | — | |
| 2 | Common | Common Stock | 2025-11-11 | M | A | 5,175 | $9.66 | 15,152 | D | — | — | |
| 3 | Derivative | Non-Qualified Stock Option (Right to Buy) | 2025-11-11 | M | D | 5,175 | $0.00 | 0 | D | $9.66 · 2016-08-01 to 2026-07-01 | 5,175 Common Stock | (F1) This option shall vest and become exercisable as to 5,175 shares divided into equal monthly installments such that the option shall be 100% vested on January 1, 2017. |